When prepared in a fluid therapy pharmacy, no compounded parenteral product prescription may be dispensed unless a label is affixed to the container in which such drug is dispensed and such label includes:
(A) The telephone number of the pharmacy, and the name and address of the pharmacy as it appears on the terminal distributor of dangerous drugs license;
(B) The full name of the patient for whom the drug is prescribed;
(C) The full name of the prescriber;
(D) Directions for use of the drug which must include route of administration;
(E) The date of dispensing;
(F) Any cautions which may be required by federal or state law;
(G) The name and amount of the drug(s) added;
(H) The name and volume of the parenteral solution;
(I) The quantity of drug dispensed, if appropriate;
(J) Beyond use date;
(K) Storage conditions.
Effective:
01/01/2011
R.C.
119.032 review dates:
12/01/2013
Promulgated
Under: 119.03
Statutory
Authority:
3715.69,
3719.28,
4729.26
Rule
Amplifies:
3715.64,
3719.08
Prior
Effective Dates: 3/1/99, 1/1/04, 1/1/09